Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 7
2006 8
2007 7
2008 15
2009 16
2010 35
2011 45
2012 44
2013 45
2014 48
2015 38
2016 58
2017 24
2018 16
2019 18
2020 12
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

412 results
Results by year
Filters applied: . Clear all
Page 1
Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial.
Daneshi-Maskooni M, Keshavarz SA, Qorbani M, Mansouri S, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. BMC Complement Altern Med. 2019 Mar 12;19(1):59. doi: 10.1186/s12906-019-2465-0. BMC Complement Altern Med. 2019. PMID: 30871514 Free PMC article. Clinical Trial.
The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial.
Daneshi-Maskooni M, Keshavarz SA, Mansouri S, Qorbani M, Alavian SM, Badri-Fariman M, Jazayeri-Tehrani SA, Sotoudeh G. Daneshi-Maskooni M, et al. Among authors: alavian sm. Trials. 2017 Jun 7;18(1):260. doi: 10.1186/s13063-017-1979-3. Trials. 2017. PMID: 28592311 Free PMC article. Clinical Trial.
Art and viral hepatitis elimination programmes.
Nima M, Karimi-Sari H, Alavian SM. Nima M, et al. Among authors: alavian sm. J Virus Erad. 2018 Jan 1;4(1):59-60. J Virus Erad. 2018. PMID: 29568557 Free PMC article.
Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.
Cheraghpour M, Imani H, Ommi S, Alavian SM, Karimi-Shahrbabak E, Hedayati M, Yari Z, Hekmatdoost A. Cheraghpour M, et al. Among authors: alavian sm. Phytother Res. 2019 Aug;33(8):2118-2125. doi: 10.1002/ptr.6406. Epub 2019 Jul 1. Phytother Res. 2019. PMID: 31264313 Clinical Trial.
Harm reduction during the COVID-19 outbreak in Iran.
Karimi-Sari H, Sharafi H, Rezaee-Zavareh MS, Alavian SM. Karimi-Sari H, et al. Among authors: alavian sm. Lancet Psychiatry. 2020 Aug;7(8):e57. doi: 10.1016/S2215-0366(20)30306-0. Lancet Psychiatry. 2020. PMID: 32711718 Free PMC article. No abstract available.
Hepatitis delta: the rediscovery.
Rizzetto M, Alavian SM. Rizzetto M, et al. Among authors: alavian sm. Clin Liver Dis. 2013 Aug;17(3):475-87. doi: 10.1016/j.cld.2013.05.007. Epub 2013 Jul 3. Clin Liver Dis. 2013. PMID: 23905817 Review.
Natural disasters pose a challenge for hepatitis elimination in Iran.
Pourkarim MR, Thijssen M, Alavian SM, Van Ranst M. Pourkarim MR, et al. Among authors: alavian sm. Lancet Gastroenterol Hepatol. 2019 Aug;4(8):581-582. doi: 10.1016/S2468-1253(19)30197-9. Lancet Gastroenterol Hepatol. 2019. PMID: 31292070 No abstract available.
412 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page